precision medicine
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Micheal
Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back. Read More
Regeneron, Illumina, 17 U.S. health systems invest combined $320M in Truveta Genome Project
Micheal
As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic ...
